Toll-Like Receptor 2 signaling protects mice from tumor development in a mouse model of Colitis-induced cancer

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Lowe, Emily L ^a   Crother, Timothy R ^a   Rabizadeh, Shervin ^a   Hu, Bing ^a   Wang, Hanlin ^a   Chen, Shuang ^a   Shimada, Kenichi ^a   Wong, Michelle H ^a   Michelsen, Kathrin S ^a   Arditi, Moshe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER SUSCEPTIBILITY; COLITIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTESTINE CRYPT; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE; ABERRANT CRYPT FOCUS; ANIMAL; C57BL MOUSE; COLORECTAL TUMOR; DISEASE MODEL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALE; MOUSE MUTANT; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PATHOLOGY;

MUS;

ABERRANT CRYPT FOCI; ANIMALS; COLITIS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASTIC PROCESSES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 77958610178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013027     Document Type: Article

References (62)

1. Baumgart D, Carding S (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640.
2. Clevers H (2004) At the crossroads of inflammation and cancer. Cell 118: 671-674.
3. Coussens L, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867.
4. Xiao H, Gulen M, Qin J, Yao J, Bulek K, et al. (2007) The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26: 461-475.
5. Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, et al. (2006) Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 169: 1686-1700.
6. Rakoff-Nahoum S, Hao L, Medzhitov R (2006) Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25: 319-329.
7. Lee J, Mo J-H, Katakura K, Alkalay I, Rucker AN, et al. (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8: 1327-1336.
8. Cario E, Gerken G, Podolsky D (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374.
9. Fukata M, Michelsen K, Eri R, Thomas L, Hu B, et al. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055-1065.
10. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
11. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, et al. (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877.
12. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
13. Cario E, Gerken G, Podolsky DK (2004) Toll-like receptor 2 enhances ZO-1- associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238.
14. Ey B, Eyking A, Gerken G, Podolsky DK, Cario E (2009) TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J Biol Chem 284: 22332-22343.
15. Taupin D, Podolsky DK (2003) Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4: 721-732.
16. Redecke V, Hacker H, Datta S, Fermin A, Pitha P, et al. (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172: 2739-2743.
17. Re F, Strominger J (2001) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276: 37692-37699.
18. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, et al. (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signalregulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171: 4984-4989.
19. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, et al. (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172: 4733-4743.
20. Sutmuller R, den Brok M, Kramer M, Bennink E, Toonen L, et al. (2006) Tolllike receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116: 485-494.
21. Liu H, Komai-Koma M, Xu D, Liew F (2006) Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 103: 7048-7053.
22. Chen Q, Davidson TS, Huter EN, Shevach EM (2009) Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival. J Immunol 183: 4458-4466.
23. Rakoff-Nahoum S, Medzhitov R (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127.
24. Fukata M, Chen A, Vamadevan A, Cohen J, Breglio K, et al. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133: 1869-1881.
25. Fukata M, Hernandez Y, Conduah D, Cohen J, Chen A, et al. (2009) Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis 15: 997-1006.
26. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, et al. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231.
27. Zhang R, Li Y, Beck PL, McCafferty D-M (2007) Toll-like receptor 4 regulates colitis-associated adenocarcinoma development in interleukin-10-deficient (IL-10(-/-)) mice. Biochem Soc Trans 35: 1375-1376.
28. Denning T, Wang Y, Patel S, Williams I, Pulendran B (2007) Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8: 1086-1094.
29. Manicassamy S, Ravindran R, Deng J, Oluoch H, Denning TL, et al. (2009) Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nature Medicine 15: 401-409.
30. Greten F, Eckmann L, Greten T, Park J, Li Z, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
31. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, et al. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94: 965-973.
32. Popivanova B, Kitamura K, Wu Y, Kondo T, Kagaya T, et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118: 560-570.
33. Ortega-Cava CF, Ishihara S, Rumi MAK, Kawashima K, Ishimura N, et al. (2003) Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170: 3977-3985.
34. Gregorieff A, Pinto D, Begthel H, Destree O, Kielman M, et al. (2005) Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129: 626-638.
35. Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A (2000) Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitisassociated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 21: 757-768.
36. Khare S, Chaudhary K, Bissonnette M, Carroll R (2009) Aberrant crypt foci in colon cancer epidemiology. Methods Mol Biol 472: 373-386.
37. Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, et al. (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4: 217-220.
38. Grivennikov S, Karin E, Terzic J, Mucida D, Yu G-Y, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
39. Maynard CL, Weaver CT (2009) Intestinal effector T cells in health and disease. Immunity 31: 389-400.
40. Wu S, Rhee K-J, Albesiano E, Rabizadeh S, Wu X, et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Medicine 15: 1016-1022.
41. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, et al. (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967-974.
42. Yang L, Huang J, Ren X, Gorska AE, Chytil A, et al. (2008) Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 23-35.
43. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, et al. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: ''N1'' versus ''N2'' TAN. Cancer Cell 16: 183-194.
44. Dinapoli MR, Calderon CL, Lopez DM (1996) The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 183: 1323-1329.
45. Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, et al. (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Research 61: 7305-7309.
46. Guruvayoorappan C (2008) Tumor versus tumor-associated macrophages: how hot is the link? Integrative cancer therapies 7: 90-95.
47. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, et al. (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111: 871-885.
48. Halliwell B (1997) What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411: 157-160.
49. Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844.
50. Zaph C, Troy AE, Taylor BC, Berman-Booty LD, Guild KJ, et al. (2007) Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446: 552-556.
51. Chung Y-C, Chang Y-F (2003) Serum interleukin-6 levels reflect the disease status of colorectal cancer. Journal of surgical oncology 83: 222-226.
52. Galizia G, Orditura M, Romano C, Lieto E, Castellano P, et al. (2002) Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 102: 169-178.
53. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809.
54. Bettelli E, Carrier Y, Gao W, Korn T, Strom T, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
55. Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
56. Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, et al. (2009) Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/ OX40L axis toward Th17-cell differentiation. Blood 114: 2639-2648.
57. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
58. Taylor KD, Targan SR, Mei L, Ippoliti AF, McGovern D, et al. (2008) IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm Bowel Dis 14: 1185-1191.
59. Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, et al. (2009) Tregulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Research 69: 5490-5497.
60. O'Connor W, Kamanaka M, Booth CJ, Town T, Nakae S, et al. (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10: 603-609.
61. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, et al. (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 107: 5540-5544.
62. Boulard O, Asquith MJ, Powrie F, Maloy KJ (2010) TLR2-independent induction and regulation of chronic intestinal inflammation. Eur J Immunol 40: 516-524.